Source:http://linkedlifedata.com/resource/pubmed/id/11210720
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2001-2-8
|
pubmed:abstractText |
Estrogen can enhance or reduce lymphocyte functions in vitro depending on dose and exposure duration. The purpose of this study was to determine the effect of in vivo 17 beta-estradiol (E2) on apoptosis and necrosis in lymphoid tissue of female C567BL/6 mice. Animals were ovariectomized (OVX), ovariectomized and 17 beta-estradiol supplemented (OVX + E2; 71 micrograms E2 per day for 14 days), sham ovariectomized (SHAM), or unhandled controls (CONTROL). Thymus and spleen were removed aseptically, cells dispersed into single cell suspensions in RPMI-1640, and measures of cell damage performed: an annexin V flow cytometric assay for markers of apoptosis and an enzyme-linked immunoassay for measures of DNA fragmentation and necrosis. OVX + E2 mice had 620 +/- 72 pg/ml 17 beta-estradiol in serum in contrast to OVX mice which had 7.6 +/- 5 pg/ml, the SHAM mice which had 2.8 +/- 1 pg/ml of serum E2, and the CONTROL mice which had 3.9 +/- 0.8 pg/ml of serum E2 (p < 0.001). There was a significantly lower percentage of viable thymocytes in OVX + E2 mice compared to the other treatment conditions (p < 0.001, respectively). There was also a significantly higher percentage of annexin V positive thymocytes in OVX + E2 mice (p < 0.005). Measures of DNA fragmentation by ELISA were higher in splenocytes from OVX + E2 mice than in the OVX, SHAM or CONTROL mice (p < 0.005). These results suggest that supraphysiological levels of estrogen in vivo induce damage in lymphoid cells; however, the impact of estrogen associated lymphoid tissue damage on specific immune functions remains to be determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1451-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11210720-Animals,
pubmed-meshheading:11210720-Annexin A5,
pubmed-meshheading:11210720-Apoptosis,
pubmed-meshheading:11210720-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:11210720-Estradiol,
pubmed-meshheading:11210720-Female,
pubmed-meshheading:11210720-Flow Cytometry,
pubmed-meshheading:11210720-Humans,
pubmed-meshheading:11210720-Lymphoid Tissue,
pubmed-meshheading:11210720-Mice,
pubmed-meshheading:11210720-Mice, Inbred C57BL,
pubmed-meshheading:11210720-Necrosis,
pubmed-meshheading:11210720-Ovariectomy,
pubmed-meshheading:11210720-Spleen,
pubmed-meshheading:11210720-Thymus Gland
|
pubmed:year |
2000
|
pubmed:articleTitle |
Supraphysiological level of estrogen exposure in vivo increases lymphoid cell death in mice.
|
pubmed:affiliation |
Department of Health Studies and Gerontology, University of Waterloo, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|